FDA Inspection
Accra-Pac, Inc.Accra-Pac, Inc. – FDA Inspection, Mar 5, 2026
Record Details
This FDA Inspection record concerns Accra-Pac, Inc., with an inspection on March 5, 2026, issued by the Detroit District Office, covering human drugs.
View Company Profile
ID · bf4bc3ba-f0e2-46ed-94db-9b0405913265
Inspection Facts
- Inspection number
- 1288190
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.105(a)Identification of containers, lines, equipment
- 21 CFR 211.67(c)Cleaning/maintenance records not kept
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.80(a)Written Procedures Not Followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Accra-Pac, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| September 2, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2021 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| April 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Accra-Pac, Inc.
- FDA Inspection 1178990 - 2022-09-02
- FDA Inspection 1157187 - 2021-11-05
- FDA Inspection 1009786 - 2017-04-05
- FDA Inspection 904407 - 2014-11-21
- FDA Inspection 855917 - 2013-11-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.